Literature DB >> 6663081

Antibiotic therapy of experimental airborne Legionnaires' disease.

D H Gibson, R B Fitzgeorge, A Baskerville.   

Abstract

The efficacy of erythromycin, gentamicin and rifampicin has been compared in the treatment of experimental airborne Legionnaires' disease in guinea-pigs. Evaluation was based on survival of animals after 1LD50 or 10LD50 infection, on numbers of Legionella pneumophila in the lungs and on the extent of histopathological lesions. All three drugs were effective in increasing survival in 1LD50 infections, but only rifampicin gave any protection against 10LD50 infection. Rifampicin was the most effective agent in eliminating viable L. pneumophila from the lungs and also in preventing pulmonary lesions.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6663081     DOI: 10.1016/s0163-4453(83)97034-2

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  6 in total

1.  Legionnaires' disease: a review of 79 community acquired cases in Nottingham.

Authors:  M A Woodhead; J T Macfarlane
Journal:  Thorax       Date:  1986-08       Impact factor: 9.139

2.  Antimicrobial therapy of experimental Legionella micdadei pneumonia in guinea pigs.

Authors:  A W Pasculle; J N Dowling; F N Frola; D A McDevitt; M A Levi
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

3.  Rifampin resistance of Legionella pneumophila is not increased during therapy for experimental Legionnaires disease: study of rifampin resistance using a guinea pig model of Legionnaires disease.

Authors:  P H Edelstein
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

Review 4.  Treatment of Legionnaires' disease. Current recommendations.

Authors:  J Roig; A Carreres; C Domingo
Journal:  Drugs       Date:  1993-07       Impact factor: 9.546

5.  Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs.

Authors:  A Saito; K Sawatari; Y Fukuda; M Nagasawa; H Koga; A Tomonaga; H Nakazato; K Fujita; Y Shigeno; Y Suzuyama
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

6.  Inhibition of Legionella pneumophila multiplication within human macrophages by antimicrobial agents.

Authors:  J L Vildé; E Dournon; P Rajagopalan
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.